The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This session will feature a selection of the best abstracts submitted to the micobiome and microbial therapy section which encompass DGBI, IBD, cancer and liver disease.
This session will explore the role of the microbiome in the pathogenesis of Clostridioides difficile colitis, assess real-world data on novel microbiome therapeutics, and review innovative delivery modalities for these treatments…
This is the second year of the debate format. We will cover two important clinical topics: Are high fiber diets really good for you? And should we be exploring off-label use of live biotherapeutic products? This will consist of speakers on each topic present different viewpoints on the question…